Anima Holding SA
BOVESPA:ANIM3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Anima Holding SA
BOVESPA:ANIM3
|
BR |
|
A
|
Acticor Biotech SA
PAR:ALACT
|
FR |
|
H
|
H & M Hennes & Mauritz AB
OTC:HMRZF
|
SE |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
Wall Street
Price Targets
ANIM3 Price Targets Summary
Anima Holding SA
According to Wall Street analysts, the average 1-year price target for
ANIM3
is 6.6 BRL
with a low forecast of 4.85 BRL and a high forecast of 9.45 BRL.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANIM3's stock price target?
Price Target
6.6
BRL
According to Wall Street analysts, the average 1-year price target for
ANIM3
is 6.6 BRL
with a low forecast of 4.85 BRL and a high forecast of 9.45 BRL.
What is Anima Holding SA's Revenue forecast?
Projected CAGR
4%
For the last 14 years the
compound annual growth rate for
Anima Holding SA's revenue is
22%.
The projected
CAGR
for the next 3 years is
4%.
What is Anima Holding SA's Operating Income forecast?
Projected CAGR
9%
The
compound annual growth rate
of Anima Holding SA's operating income for the next 2 years is
9%.
What is Anima Holding SA's Net Income forecast?
Projected CAGR
85%
The
compound annual growth rate
of Anima Holding SA's net income for the next 2 years is
85%.
